blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1963360

EP1963360 - NEUREGULIN VARIANTS AND METHODS OF SCREENING AND USING THEREOF [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  29.10.2010
Database last updated on 19.10.2024
Most recent event   Tooltip29.10.2010Application deemed to be withdrawnpublished on 01.12.2010  [2010/48]
Applicant(s)For all designated states
Zensun (Shanghai) Science and Technology Limited
Suite C, Level 2 328 Bibo Road Zhangjiang Hi-Tech Park Pudong
Shanghai 201203 / CN
[2008/36]
Inventor(s)01 / ZHOU, Mingdong
77 Fangdian Road Unit 4, Room 1102 Pudong
Shanghai 200135 / CN
 [2008/36]
Representative(s)Weber, Martin, et al
Jones Day
Prinzregentenstrasse 11
80538 München / DE
[N/P]
Former [2008/36]Weber-Quitzau, Martin, et al
Jones Day Prinzregentenstrasse 11
80538 München / DE
Application number, filing date06828213.604.12.2006
[2008/36]
WO2006CN03240
Priority number, dateUS2005029387902.12.2005         Original published format: US 293879
[2008/36]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2007062594
Date:07.06.2007
Language:EN
[2007/23]
Type: A1 Application with search report 
No.:EP1963360
Date:03.09.2008
Language:EN
The application published by WIPO in one of the EPO official languages on 07.06.2007 takes the place of the publication of the European patent application.
[2008/36]
Search report(s)International search report - published on:CN07.06.2007
(Supplementary) European search report - dispatched on:EP02.02.2010
ClassificationIPC:C07K14/435, C12N15/12, A61K38/17, G01N33/68, A61P25/18, A61P9/00, A61P31/12
[2008/36]
CPC:
C07K14/4756 (EP,US); A61P25/00 (EP); A61P25/18 (EP);
A61P31/12 (EP); A61P9/00 (EP); A61P9/10 (EP);
G01N33/6872 (EP,US); G16B15/00 (EP,US); G16B15/30 (EP,US);
G16B20/00 (EP,US); G16B20/30 (EP,US); G16B20/50 (EP,US);
A61K38/00 (EP,US); G01N2333/4756 (EP,US); G01N2500/02 (EP,US);
G01N2800/32 (EP,US); Y02A90/10 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2008/36]
Extension statesAL02.07.2008
BA02.07.2008
HR02.07.2008
MK02.07.2008
RS02.07.2008
TitleGerman:NEUREGULINVARIANTEN UND VERFAHREN ZUM SCREENING UND DIE ANWENDUNG DAVON[2008/36]
English:NEUREGULIN VARIANTS AND METHODS OF SCREENING AND USING THEREOF[2008/36]
French:VARIANTES DE LA NEUREGULINE ET PROCEDES DE CRIBLAGE ET D'UTILISATION DE CELLES-CI[2008/36]
Entry into regional phase02.07.2008National basic fee paid 
02.07.2008Search fee paid 
02.07.2008Designation fee(s) paid 
02.07.2008Examination fee paid 
Examination procedure02.07.2008Amendment by applicant (claims and/or description)
02.07.2008Examination requested  [2008/36]
04.05.2010Application deemed to be withdrawn, date of legal effect  [2010/48]
17.06.2010Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2010/48]
Fees paidRenewal fee
15.12.2008Renewal fee patent year 03
Penalty fee
Additional fee for renewal fee
31.12.200904   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]US5367060  (VANDLEN RICHARD L [US], et al) [Y] 5-7,32-34 * Col 6 line 52 -Col 7 line 28 Col 8 lines 24-40 *;
 [Y]US6136558  (BALLINGER MARCUS D [US], et al) [Y] 5-7,32-34 * Claims 1-6,18-28 *;
 [A]WO0248191  (YEDA RES & DEV [IL], et al) [A] 1-7,17,19,32,34* the whole document *;
 [Y]WO03099300  (ZENSUN SHANGHAI SCI TECH LTD [CN], et al) [Y] 5-7,32-34 * Claims 1-3 Page 12 lines 10-27 *;
 [Y]CN1498656  (ZESHENG SCI TECH CO LTD SHANGH [CN]) [Y] 5-7,32-34 * Abstract SEQ ID NO 2 *;
 [XY]  - LUO C ET AL, "Computational Analysis of Molecular Basis of 1:1 Interactions of NRG-1beta Wild-Type and Variants With ErbB3 and ErbB4", PROTEINS: STRUCTURE, FUNCTION AND GENETICS, JOHN WILEY & SONS, INC, US, (20050408), vol. 59, no. 4, ISSN 0887-3585, pages 742 - 756, XP003013826 [X] 1-4,17,19 * Abstract Figure 8A * [Y] 5-7,32-34

DOI:   http://dx.doi.org/10.1002/prot.20443
 [A]  - CORFAS G ET AL, "Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia", NATURE NEUROSCIENCE, NATURE AMERICA, INC, US, (20040601), vol. 7, no. 6, ISSN 1097-6256, pages 575 - 580, XP002996357 [A] 7 * Abstract *
International search[XP]CN1715926  (ZESHENG SCIENCE AND TECHNOLOGY [CN]);
 [X]  - LUO C. ET AL., "Computational Analysis of Molecular Basis of 1:1 Interactions of NRG-1beta Wild-Type and Variants With ErbB3 and ErbB4", PROTEINS: STRUCTURE, FUNCTION, AND BIOINFORMATICS, (20050408), vol. 59, no. 4, pages 742 - 756, XP003013826

DOI:   http://dx.doi.org/10.1002/prot.20443
 [A]  - BRITISCH S. ET AL., "The ErbB2 and ErbB3 receptors and their ligand, neuregulin-1, are essential for development of the sympathetic nervous system", GENES DEV., (1998), vol. 12, pages 1825 - 1836, XP003013823
 [A]  - JONES J.T. ET AL., "Binding Interaction of the Heregulinbeta egf Domain with ErbB3 and ErbB4 Receptors Assessed by Alanine Scanning Mutagenesis", J. BIOL. CHEM., (19980508), vol. 273, no. 19, pages 11667 - 11674, XP003013824
 [A]  - MASSOVA I. ET AL., "Computational Alanine Scanning To Protein-Protein Interactions: A Novel Approach To Evaluate Binding Free Energies", J. AM. CHEM. SOC., (19990915), vol. 121, no. 36, pages 8133 - 8143, XP003013825

DOI:   http://dx.doi.org/10.1021/ja990935j
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.